Health & Fitness
Wed, September 7, 2011Tue, September 6, 2011Mon, September 5, 2011Sun, September 4, 2011Sat, September 3, 2011Fri, September 2, 2011Thu, September 1, 2011Wed, August 31, 2011Tue, August 30, 2011Anacor Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
//health-fitness.news-articles.net/content/2011/ .. -stifel-nicolaus-2011-healthcare-conference.html
Published in Health and Fitness on Friday, September 2nd 2011 at 11:23 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
PALO ALTO, Calif.--([ BUSINESS WIRE ])--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the companya™s Chief Executive Officer, will provide a company overview at the Stifel Nicolaus 2011 Healthcare Conference at 3:50 p.m. ET on Thursday, September 8, 2011 in Boston, Massachusetts. The presentation will be webcast live and may be accessed under aEvents and Presentationsa on the Investors page of Anacora™s website at [ www.anacor.com ]. A replay will also be available for three months following the presentation.
About Anacor Pharmaceuticals
Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor has discovered five compounds which are currently in clinical development, including its three lead programs: AN2690, a topical antifungal for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for the treatment of psoriasis and atopic dermatitis; and GSK 2251052, or GSK a052 (formerly referred to as AN3365), a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which has been licensed to GlaxoSmithKline under the companies' research and development agreement. In addition, Anacor is developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis. For more information visit [ http://www.anacor.com ].